Neuroscience
Antidepressant
8%
Antipsychotic
29%
Aripiprazole
7%
Auditory Hallucination
12%
Behavior (Neuroscience)
5%
Brain Activation
9%
Default Mode Network
9%
Dementia Praecox
100%
Depression
12%
Dorsolateral Prefrontal Cortex
5%
Functional Connectivity
7%
Functional Magnetic Resonance Imaging
6%
Glutamic Acid
6%
Gray Matter
6%
Hallucination
29%
Meta-Analysis
9%
Negative Syndrome
53%
Nuclear Magnetic Resonance Spectroscopy
7%
Positive Syndrome
19%
Prefrontal Cortex
7%
Psychiatry
8%
Psychoactive Drug
5%
Psychosis
45%
Randomized Controlled Trial
10%
Reactive Attachment Disorder
5%
Risperidone
6%
Schizophrenia Spectrum Disorder
8%
Somatics
5%
Survival Analysis
6%
Temporoparietal Junction
7%
Transcranial Direct Current Stimulation
5%
Transcranial Magnetic Stimulation
31%
Typical Antipsychotic
25%
Psychology
Conflict of Interest
5%
Decision Aid
5%
Depression
17%
Exploratory Factor Analysis
5%
Goal-Directed Behavior
5%
Hallucination
24%
Healthcare
14%
Mental Health
23%
Mental Illness
7%
Meta-Analysis
9%
Neuroticism
5%
Proportional Hazards Regression Model
8%
Psychiatric Disorder
7%
Psychometrics
10%
Psychotic Disorder
39%
Quality of Life
11%
Rating Scale
13%
Regression Analysis
7%
Schizophrenia
77%
Social Functioning
5%
Systematic Review
10%
Keyphrases
Antipsychotics
17%
Brain Activation
5%
Depressive Symptoms
5%
First-episode Psychosis
17%
Negative Symptoms
21%
Patients with Schizophrenia
10%
Pharmacotherapy
6%
Positive Symptoms
11%
Psychosis
13%
Psychosocial Functioning
5%
Psychotic Disorders
17%
Recent-onset Schizophrenia
5%
Repetitive Transcranial Magnetic Stimulation (rTMS)
14%
Risperidone
5%
Routine Outcome Monitoring
9%
Schizophrenia
15%
Schizophrenia Spectrum Disorders
6%
Sexual Behavior
9%
Sham
7%
Suicide
5%
Suicide Rate
5%
Symptom Severity
6%
Transcranial Direct-current Stimulation (tDCS)
5%
